Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
Ciro Celsa(Department of Health), Fable Zustovich, Marilena Di Napoli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Raffaele Giusti(CTO Andrea Alesini), Amit G. Singal(Southwestern Medical Center), Celina Ang(Icahn School of Medicine at Mount Sinai), Pei‐Chang Lee(National Yang Ming Chiao Tung University), Francesca Salani(Scuola Superiore Sant'Anna), Kornelius Schulze(Universität Hamburg), Antonio D’Alessio(Hammersmith Hospital), Giuseppe Cabibbo(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Alessandro Parisi(Marche Polytechnic University), Johann von Felden(Universität Hamburg), Naoshi Nishida(Kindai University Hospital), Masatoshi Kudo(Kindai University), Caterina Vivaldi(Scuola Superiore Sant'Anna), Paul El Tomb(University of Oklahoma Medical Center), Susanna V. Ulahannan(Oklahoma State University Oklahoma City), Bernhard Scheiner(Medical University of Vienna), Anwaar Saeed(University of Pittsburgh), Claudia Angela Maria Fulgenzi(Università Campus Bio-Medico), Samuel Phen(The University of Texas Southwestern Medical Center), Elena Verzoni(Fondazione IRCCS Istituto Nazionale dei Tumori), Anjana Pillai(University of Chicago), Robert Thimme(University of Freiburg), Matthias Pinter(Medical University of Vienna), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Gianluca Masi(University of Pisa), Ernesto Rossi(Agostino Gemelli University Polyclinic), Brooke Wietharn(The University of Kansas Cancer Center), Lorenza Rimassa(Humanitas University), Giulia Francesca Manfredi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hong Jae Chon(CHA University Bundang Medical Center), Peter R. Galle(Johannes Gutenberg University Mainz), Yi‐Hsiang Huang(First Hospital of Lanzhou University), Martin Schönlein(Universität Hamburg), Paola Ermacora(Presidio Ospedaliero), Francesco Verderame(Ospedale Vincenzo Cervello), Antonello Veccia(Ospedale Santa Chiara), Bernardo Stefanini(Azienda USL di Bologna), Natascha Roehlen(University of Freiburg), Arndt Vogel(Princess Margaret Cancer Centre), Annamaria Catino(Istituto Tumori Bari), Anuhya Gampa(University of Chicago), Henning Wege(Universität Hamburg), Giuseppe Aprile(Ospedale Santa Maria della Misericordia di Udine), Wei‐Fan Hsu(China Medical University), Lorenzo Antonuzzo(Azienda Ospedaliero-Universitaria Careggi), Pamela Francesca Guglielmini(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Jaekyung Cheon(CHA University Bundang Medical Center)
Cited by 62
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k